Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

NCT02215798 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02215798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02215798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
Not reported
Enrollment
269 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain